APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cough and Cold Remedie

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cough and Cold Remedie Market Outlook and Growth Opportunities 2026

19 December 2025198 pages

Choose your research edition.

Industry ResearchCough and Cold Remedie Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Cough and Cold Remedie Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Cough and Cold Remedie Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cough and Cold Remedie Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Cough and Cold Remedie Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Cough and Cold Remedie market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cough and Cold Remedie is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cough and Cold Remedie is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cough and Cold Remedie is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cough and Cold Remedie market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cough and Cold Remedie market include Sun Pharmaceutical Industries, Johnson & Johnson, Novartis, Pfizer, GlaxoSmithKline, Bayer, AstraZeneca, Reckitt Benckiser Group and Procter & Gamble, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cough and Cold Remedie market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cough and Cold Remedie and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cough and Cold Remedie revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cough and Cold Remedie market.

Cough and Cold Remedie Segment by Company

Sun Pharmaceutical Industries

Johnson & Johnson

Novartis

Pfizer

GlaxoSmithKline

Bayer

AstraZeneca

Reckitt Benckiser Group

Procter & Gamble

Prestige Brands Holdings

Cough and Cold Remedie Segment by Type

Bronchodilators

Expectorants

Antihistamines

Antibiotics

Decongestants

Others

Cough and Cold Remedie Segment by Application

OTC

Rx

Cough and Cold Remedie Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Cough and Cold Remedie status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cough and Cold Remedie key companies, revenue, market share, and recent developments.

3. To split the Cough and Cold Remedie breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cough and Cold Remedie market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cough and Cold Remedie significant trends, drivers, influence factors in global and regions.

6. To analyze Cough and Cold Remedie competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cough and Cold Remedie market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cough and Cold Remedie and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cough and Cold Remedie.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cough and Cold Remedie industry.

Chapter 3: Detailed analysis of Cough and Cold Remedie company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cough and Cold Remedie in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cough and Cold Remedie in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cough and Cold Remedie Industry Trends Table 2. Cough and Cold Remedie Industry Drivers Table 3. Cough and Cold Remedie Industry Opportunities and Challenges Table 4. Cough and Cold Remedie Industry Restraints Table 5. Global Cough and Cold Remedie Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cough and Cold Remedie Revenue Share by Company (2021-2026) Table 7. Global Cough and Cold Remedie Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cough and Cold Remedie Key Company Manufacturing Base & Headquarters Table 9. Global Cough and Cold Remedie Company, Product Type & Application Table 10. Global Cough and Cold Remedie Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cough and Cold Remedie by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Bronchodilators Table 15. Significant Companies of Expectorants Table 16. Significant Companies of Antihistamines Table 17. Significant Companies of Antibiotics Table 18. Significant Companies of Decongestants Table 19. Significant Companies of Others Table 20. Global Cough and Cold Remedie Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Cough and Cold Remedie Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Cough and Cold Remedie Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Cough and Cold Remedie Sales Value Share by Type (2021-2026) Table 24. Global Cough and Cold Remedie Sales Value Share by Type (2027-2032) Table 25. Significant Companies of OTC Table 26. Significant Companies of Rx Table 27. Global Cough and Cold Remedie Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Cough and Cold Remedie Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Cough and Cold Remedie Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Cough and Cold Remedie Sales Value Share by Application (2021-2026) Table 31. Global Cough and Cold Remedie Sales Value Share by Application (2027-2032) Table 32. Global Cough and Cold Remedie Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Cough and Cold Remedie Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Cough and Cold Remedie Sales Value Share by Region (2021-2026) Table 35. Global Cough and Cold Remedie Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Cough and Cold Remedie Sales Value Share by Region (2027-2032) Table 37. Global Cough and Cold Remedie Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Cough and Cold Remedie Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Cough and Cold Remedie Sales Value Market Share by Country (2021-2026) Table 40. Global Cough and Cold Remedie Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Cough and Cold Remedie Sales Value Market Share by Country (2027-2032) Table 42. Sun Pharmaceutical Industries Company Information Table 43. Sun Pharmaceutical Industries Business Overview Table 44. Sun Pharmaceutical Industries Cough and Cold Remedie Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Sun Pharmaceutical Industries Cough and Cold Remedie Product Portfolio Table 46. Sun Pharmaceutical Industries Recent Development Table 47. Johnson & Johnson Company Information Table 48. Johnson & Johnson Business Overview Table 49. Johnson & Johnson Cough and Cold Remedie Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Johnson & Johnson Cough and Cold Remedie Product Portfolio Table 51. Johnson & Johnson Recent Development Table 52. Novartis Company Information Table 53. Novartis Business Overview Table 54. Novartis Cough and Cold Remedie Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Novartis Cough and Cold Remedie Product Portfolio Table 56. Novartis Recent Development Table 57. Pfizer Company Information Table 58. Pfizer Business Overview Table 59. Pfizer Cough and Cold Remedie Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Pfizer Cough and Cold Remedie Product Portfolio Table 61. Pfizer Recent Development Table 62. GlaxoSmithKline Company Information Table 63. GlaxoSmithKline Business Overview Table 64. GlaxoSmithKline Cough and Cold Remedie Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. GlaxoSmithKline Cough and Cold Remedie Product Portfolio Table 66. GlaxoSmithKline Recent Development Table 67. Bayer Company Information Table 68. Bayer Business Overview Table 69. Bayer Cough and Cold Remedie Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Bayer Cough and Cold Remedie Product Portfolio Table 71. Bayer Recent Development Table 72. AstraZeneca Company Information Table 73. AstraZeneca Business Overview Table 74. AstraZeneca Cough and Cold Remedie Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. AstraZeneca Cough and Cold Remedie Product Portfolio Table 76. AstraZeneca Recent Development Table 77. Reckitt Benckiser Group Company Information Table 78. Reckitt Benckiser Group Business Overview Table 79. Reckitt Benckiser Group Cough and Cold Remedie Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Reckitt Benckiser Group Cough and Cold Remedie Product Portfolio Table 81. Reckitt Benckiser Group Recent Development Table 82. Procter & Gamble Company Information Table 83. Procter & Gamble Business Overview Table 84. Procter & Gamble Cough and Cold Remedie Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Procter & Gamble Cough and Cold Remedie Product Portfolio Table 86. Procter & Gamble Recent Development Table 87. Prestige Brands Holdings Company Information Table 88. Prestige Brands Holdings Business Overview Table 89. Prestige Brands Holdings Cough and Cold Remedie Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Prestige Brands Holdings Cough and Cold Remedie Product Portfolio Table 91. Prestige Brands Holdings Recent Development Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Cough and Cold Remedie Product Image Figure 2. Global Cough and Cold Remedie Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cough and Cold Remedie Market Size (2021-2032) & (US$ Million) Figure 4. Global Cough and Cold Remedie Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Bronchodilators Image Figure 8. Expectorants Image Figure 9. Antihistamines Image Figure 10. Antibiotics Image Figure 11. Decongestants Image Figure 12. Others Image Figure 13. Global Cough and Cold Remedie Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Cough and Cold Remedie Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Cough and Cold Remedie Sales Value Share by Type (2021-2032) Figure 16. OTC Image Figure 17. Rx Image Figure 18. Global Cough and Cold Remedie Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Cough and Cold Remedie Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Cough and Cold Remedie Sales Value Share by Application (2021-2032) Figure 21. Global Cough and Cold Remedie Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Cough and Cold Remedie Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Cough and Cold Remedie Sales Value (2021-2032) & (US$ Million) Figure 24. North America Cough and Cold Remedie Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Cough and Cold Remedie Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Cough and Cold Remedie Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Cough and Cold Remedie Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Cough and Cold Remedie Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Cough and Cold Remedie Sales Value (2021-2032) & (US$ Million) Figure 30. South America Cough and Cold Remedie Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Cough and Cold Remedie Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Cough and Cold Remedie Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Cough and Cold Remedie Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Bronchodilators
  • Expectorants
  • Antihistamines
  • Antibiotics
  • Decongestants
  • Others
Applications
  • OTC
  • Rx
Companies covered
  • Sun Pharmaceutical Industries
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • AstraZeneca
  • Reckitt Benckiser Group
  • Procter & Gamble
  • Prestige Brands Holdings

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cough and Cold Remedie Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cough and Cold Remedie Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cough and Cold Remedie Market Dynamics
  1. 2.1 Cough and Cold Remedie Industry Trends
  2. 2.2 Cough and Cold Remedie Industry Drivers
  3. 2.3 Cough and Cold Remedie Industry Opportunities and Challenges
  4. 2.4 Cough and Cold Remedie Industry Restraints
3 Cough and Cold Remedie Market by Company
  1. 3.1 Global Cough and Cold Remedie Company Revenue Ranking in 2025
  2. 3.2 Global Cough and Cold Remedie Revenue by Company (2021-2026)
  3. 3.3 Global Cough and Cold Remedie Company Ranking (2024-2026)
  4. 3.4 Global Cough and Cold Remedie Company Manufacturing Base and Headquarters
  5. 3.5 Global Cough and Cold Remedie Company Product Type and Application
  6. 3.6 Global Cough and Cold Remedie Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cough and Cold Remedie Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cough and Cold Remedie Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cough and Cold Remedie Market by Type
  1. 4.1 Cough and Cold Remedie Type Introduction
  2. 4.1.1 Bronchodilators
  3. 4.1.2 Expectorants
  4. 4.1.3 Antihistamines
  5. 4.1.4 Antibiotics
  6. 4.1.5 Decongestants
  7. 4.1.6 Others
  8. 4.2 Global Cough and Cold Remedie Sales Value by Type
  9. 4.2.1 Global Cough and Cold Remedie Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Cough and Cold Remedie Sales Value by Type (2021-2032)
  11. 4.2.3 Global Cough and Cold Remedie Sales Value Share by Type (2021-2032)
5 Cough and Cold Remedie Market by Application
  1. 5.1 Cough and Cold Remedie Application Introduction
  2. 5.1.1 OTC
  3. 5.1.2 Rx
  4. 5.2 Global Cough and Cold Remedie Sales Value by Application
  5. 5.2.1 Global Cough and Cold Remedie Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Cough and Cold Remedie Sales Value by Application (2021-2032)
  7. 5.2.3 Global Cough and Cold Remedie Sales Value Share by Application (2021-2032)
6 Cough and Cold Remedie Regional Value Analysis
  1. 6.1 Global Cough and Cold Remedie Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cough and Cold Remedie Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cough and Cold Remedie Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cough and Cold Remedie Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cough and Cold Remedie Sales Value (2021-2032)
  7. 6.3.2 North America Cough and Cold Remedie Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cough and Cold Remedie Sales Value (2021-2032)
  10. 6.4.2 Europe Cough and Cold Remedie Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cough and Cold Remedie Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cough and Cold Remedie Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cough and Cold Remedie Sales Value (2021-2032)
  16. 6.6.2 South America Cough and Cold Remedie Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cough and Cold Remedie Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cough and Cold Remedie Sales Value Share by Country, 2025 VS 2032
7 Cough and Cold Remedie Country-level Value Analysis
  1. 7.1 Global Cough and Cold Remedie Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cough and Cold Remedie Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cough and Cold Remedie Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cough and Cold Remedie Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cough and Cold Remedie Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cough and Cold Remedie Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cough and Cold Remedie Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical Industries
  2. 8.1.1 Sun Pharmaceutical Industries Company Information
  3. 8.1.2 Sun Pharmaceutical Industries Business Overview
  4. 8.1.3 Sun Pharmaceutical Industries Cough and Cold Remedie Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical Industries Cough and Cold Remedie Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Cough and Cold Remedie Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Cough and Cold Remedie Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Cough and Cold Remedie Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Cough and Cold Remedie Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Cough and Cold Remedie Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Cough and Cold Remedie Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 GlaxoSmithKline
  26. 8.5.1 GlaxoSmithKline Company Information
  27. 8.5.2 GlaxoSmithKline Business Overview
  28. 8.5.3 GlaxoSmithKline Cough and Cold Remedie Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithKline Cough and Cold Remedie Product Portfolio
  30. 8.5.5 GlaxoSmithKline Recent Developments
  31. 8.6 Bayer
  32. 8.6.1 Bayer Company Information
  33. 8.6.2 Bayer Business Overview
  34. 8.6.3 Bayer Cough and Cold Remedie Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bayer Cough and Cold Remedie Product Portfolio
  36. 8.6.5 Bayer Recent Developments
  37. 8.7 AstraZeneca
  38. 8.7.1 AstraZeneca Company Information
  39. 8.7.2 AstraZeneca Business Overview
  40. 8.7.3 AstraZeneca Cough and Cold Remedie Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AstraZeneca Cough and Cold Remedie Product Portfolio
  42. 8.7.5 AstraZeneca Recent Developments
  43. 8.8 Reckitt Benckiser Group
  44. 8.8.1 Reckitt Benckiser Group Company Information
  45. 8.8.2 Reckitt Benckiser Group Business Overview
  46. 8.8.3 Reckitt Benckiser Group Cough and Cold Remedie Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Reckitt Benckiser Group Cough and Cold Remedie Product Portfolio
  48. 8.8.5 Reckitt Benckiser Group Recent Developments
  49. 8.9 Procter & Gamble
  50. 8.9.1 Procter & Gamble Company Information
  51. 8.9.2 Procter & Gamble Business Overview
  52. 8.9.3 Procter & Gamble Cough and Cold Remedie Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Procter & Gamble Cough and Cold Remedie Product Portfolio
  54. 8.9.5 Procter & Gamble Recent Developments
  55. 8.10 Prestige Brands Holdings
  56. 8.10.1 Prestige Brands Holdings Company Information
  57. 8.10.2 Prestige Brands Holdings Business Overview
  58. 8.10.3 Prestige Brands Holdings Cough and Cold Remedie Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Prestige Brands Holdings Cough and Cold Remedie Product Portfolio
  60. 8.10.5 Prestige Brands Holdings Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst